Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/10822
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorRangasamy, Loganathan-
dc.creatorPascual-Teresa Fernández, Beatriz de-
dc.creatorZapico Rodríguez, José María-
dc.creatorRamos González, Ana-
dc.creatorOrtín Remón, Irene-
dc.creatorCoderch Boué, Claire-
dc.date2020-
dc.date.accessioned2020-06-09T04:00:17Z-
dc.date.available2020-06-09T04:00:17Z-
dc.date.issued2020-06-09-
dc.identifier000000717528-
dc.identifier.urihttp://hdl.handle.net/10637/10822-
dc.descriptionACS Medicinal Chemistry Letters, ISSN 1948-5875, 2020, 11, 5, 713-719.-
dc.description.abstractFour potent CK2 inhibitors derived from CX-4945 are described. They are provided also of nanomolar activity against HDAC1, therefore having promising utility as dual-target agents for cancer. The linker length between the hydroxamic acid and the CX-4945 scaffold plays an important role in dictating balanced activity against the targeted enzymes. The seven-carbon linker (compound 15c) was optimal for inhibition of both CK2 and HDAC1. Remarkably, 15c showed 3.0 and 3.5 times higher inhibitory activity than the reference compounds CX-4945 (against CK2) and SAHA (against HDAC1), respectively. Compound 15c exhibited micromolar activity in cell-based cytotoxic assays against multiple cell lines.en
dc.formatapplication/pdf-
dc.language.isoen-
dc.relationFinanciado con cargo a proyectos del Ministerio (MICIU/FEDER, UE grant number RTI2018-093539-B-I00) y de la Unión Europea (European Union?s Horizon 2020 research and innovation pro-gramme under the Marie-Sklodowska-Curie grant agreement number DUALITY 746225).es
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.es-
dc.subjectDinámica molecular.-
dc.subjectDrogas de objetivos múltiples.es
dc.subjectMulti-target drugs.en
dc.subjectDual inhibitors.en
dc.titleNew Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes.-
dc.typeArtículo-
dc.description.versionPost-printen
dc.identifier.doi10.1021/acsmedchemlett.9b00561-
dc.centroUniversidad San Pablo-CEU-
Aparece en las colecciones: Facultad de Farmacia




Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.